Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Alberto Enrico, Maraolo"'
Autor:
Mazzitelli Maria, Alberto Enrico Maraolo, Claudia Cozzolino, Lolita Sasset, Anna Ferrari, Monica Basso, Eleonora Vania, Nicola Bonadiman, Vincenzo Scaglione, Anna Maria Cattelan
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-9 (2024)
Abstract Background The potential efficacy of early combination therapy, based on an antiviral plus a monoclonal antibody, for COVID-19 in severely immunocompromised patients is matter of debate. Objectives Our aim was to describe the impact on clini
Externí odkaz:
https://doaj.org/article/cf95a974b9d446789b1fbf7b1550e541
Publikováno v:
Pathogens, Vol 13, Iss 7, p 529 (2024)
There is a growing body of evidence showing no significant difference in clinical outcomes in patients with uncomplicated Gram-negative bloodstream infections (BSIs) receiving 7 or 14 days of therapy. However, the scenario may differ when complicated
Externí odkaz:
https://doaj.org/article/c251d7e309d049beb4d8af677a7304bc
Publikováno v:
Frontiers in Gastroenterology, Vol 2 (2023)
BackgroundHospital admissions for diverticulitis, a complication of diverticular disease, are very much on the increase. Prevention of diverticulitis could cut costs and save lives.AimsTo identify whether the risk of the first episode of diverticulit
Externí odkaz:
https://doaj.org/article/dc69849c01a94dc4add18ec68596d907
Autor:
Giuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, Guido Granata, Milo Gatti, Luigi Principe, Alessandro Russo, Andrea Gizzi, Rita Pallone, Antonio Cascio, Chiara Iaria
Publikováno v:
Antibiotics, Vol 12, Iss 12, p 1653 (2023)
Human Pseudomonas infections have high morbidity and mortality rates. Pseudomonas bacteria can cause sepsis or septic shock; they produce biofilm and commonly exhibit a multidrug-resistant phenotype. The choice of antimicrobial therapy in many cases
Externí odkaz:
https://doaj.org/article/5fab61fdcab54785a2464f804d11d18b
Autor:
Alberto Enrico Maraolo
Publikováno v:
Antibiotics, Vol 12, Iss 12, p 1683 (2023)
Antimicrobial resistance (AMR) is a global problem; in 2019, before the Coronavirus Disease 2019 (COVID-19) pandemic, it was responsible of more deaths than any other infectious diseases, including human immunodeficiency virus and malaria [...]
Externí odkaz:
https://doaj.org/article/f7300ab3f7dc4827a04218736a33539a
Autor:
Stefano Di Bella, Daniele Roberto Giacobbe, Alberto Enrico Maraolo, Valentina Viaggi, Roberto Luzzati, Matteo Bassetti, Francesco Luzzaro, Luigi Principe
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss , Pp 268-281 (2021)
ABSTRACT: Objectives: Ceftazidime/avibactam (CAZ-AVI), approved in 2015, is an important first-line option for Klebsiella pneumoniae carbapenemase-producing Enterobacterales (KPC-E). Although still uncommon, resistance to CAZ-AVI has emerged and may
Externí odkaz:
https://doaj.org/article/817fb4be74c841f9952daec45e0f467f
Autor:
Alberto Enrico Maraolo, Federica Licciardi, Ivan Gentile, Annalisa Saracino, Alessandra Belati, Davide Fiore Bavaro
Publikováno v:
Antibiotics, Vol 12, Iss 5, p 910 (2023)
Stenotrophomonas maltophilia (SM) represents a challenging pathogen due to its resistance profile. A systematic review of the available evidence was conducted to evaluate the best treatment of SM infections to date, focusing on trimethoprim/sulfameth
Externí odkaz:
https://doaj.org/article/734276dc804d4dd9ac2916d187174781
Autor:
Alberto Enrico Maraolo, Adriano Grossi
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 1, Pp 31-36 (2021)
Abstract Introduction Hydroxycloroquine (HCQ) has been extensively studied for treatment and prevention of coronavirus diseases 2019 (COVID‐19) from the start of the pandemic. Conflicting evidence about its usefulness has begun to accrue. Methods I
Externí odkaz:
https://doaj.org/article/bb839e96a8734ebda83053b910c1b4f4
Autor:
Daniele Roberto Giacobbe, Carolina Saffioti, Angela Raffaella Losito, Matteo Rinaldi, Caterina Aurilio, Cesare Bolla, Silvia Boni, Guglielmo Borgia, Novella Carannante, Giovanni Cassola, Giancarlo Ceccarelli, Silvia Corcione, Daniela Dalla Gasperina, Francesco Giuseppe De Rosa, Chiara Dentone, Stefano Di Bella, Nicoletta Di Lauria, Marcello Feasi, Marco Fiore, Sara Fossati, Erica Franceschini, Andrea Gori, Guido Granata, Sara Grignolo, Paolo Antonio Grossi, Giuliana Guadagnino, Filippo Lagi, Alberto Enrico Maraolo, Valeria Marinò, Maria Mazzitelli, Alessandra Mularoni, Alessandra Oliva, Maria Caterina Pace, Andrea Parisini, Francesca Patti, Nicola Petrosillo, Vincenzo Pota, Francesca Raffaelli, Marianna Rossi, Antonella Santoro, Carlo Tascini, Carlo Torti, Enrico Maria Trecarichi, Mario Venditti, Pierluigi Viale, Alessio Signori, Matteo Bassetti, Valerio Del Bono, Maddalena Giannella, Malgorzata Mikulska, Mario Tumbarello, Claudio Viscoli
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 20, Iss , Pp 43-49 (2020)
Objectives: The aim of this study was to assess colistin use in a country endemic for multidrug-resistant Gram-negative bacteria (MDR-GNB). Methods: Colistin prescription patterns were evaluated in 22 Italian centres. Factors associated with use of c
Externí odkaz:
https://doaj.org/article/99430e89aa2c4eae9aaaae3790823514
Autor:
Nicola Coppola, Alberto Enrico Maraolo, Lorenzo Onorato, Riccardo Scotto, Federica Calò, Luigi Atripaldi, Anna Borrelli, Antonio Corcione, Maria Giovanna De Cristofaro, Emanuele Durante-Mangoni, Amelia Filippelli, Gianluigi Franci, Maria Galdo, Gaspare Guglielmi, Pasquale Pagliano, Alessandro Perrella, Ornella Piazza, Marco Picardi, Rodolfo Punzi, Ugo Trama, Ivan Gentile
Publikováno v:
Antibiotics, Vol 11, Iss 9, p 1263 (2022)
Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in 2017, carbapenem-resistant organisms were listed by the WHO among the grou
Externí odkaz:
https://doaj.org/article/a5ed824849064b77baad35fa5e7892f9